Published in Hepatitis Weekly, July 18th, 2005
Data reported in this presentation includes a full 72-week analysis of 30 HCV non-responder patients enrolled in this pilot trial and builds on the results reported on 25 of these patients in November 2004 at the American Association for the Study of Liver Disease (AASLD).
Of the 30 patients evaluated at week 72, at which point...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.